about
Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implicationsDiscovery of biarylaminoquinazolines as novel tubulin polymerization inhibitorsAssay reproducibility and within-person variation of Müllerian inhibiting substance.Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women.The role of anti-Müllerian hormone in female fertility and infertility - an overview.The physiology and clinical utility of anti-Mullerian hormone in women.The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4.Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian CancerAnti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer.Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells.Anti-Müllerian hormone as a marker of ovarian reserve: an update.Serum Müllerian Inhibiting Substance/anti-Müllerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology.Anti-müllerian hormone and its clinical use in pediatrics with special emphasis on disorders of sex development.Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk.Müllerian inhibiting substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancers.Determination of serum anti-Müllerian hormone concentrations for the diagnosis of granulosa-cell tumours in mares.SMAD3 Activation: A Converging Point of Dysregulated TGF-Beta Superfamily Signaling and Genetic Aberrations in Granulosa Cell Tumor Development?Diagnostic possibilities from a serum sample-Clinical value of new methods within small animal reproduction, with focus on anti-Müllerian hormone.Anti-Müllerian hormone as an ovarian reserve marker in young cancer women who undergo ovarian tissue cryopreservation.Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine.What does anti-Müllerian hormone tell you about ovarian function?Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancerCigarette smoke exposure elicits increased autophagy and dysregulation of mitochondrial dynamics in murine granulosa cells.A tissue specific magnetic resonance contrast agent, Gd-AMH, for diagnosis of stromal endometriosis lesions: a phase I study.Anti-Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts.Serum anti-Müllerian hormone concentrations before and after treatment of an ovarian granulosa cell tumour in a cat.
P2860
Q28239980-0644856B-9FB8-4A32-B251-4C6E21187939Q33863809-CE1ECD4D-5B03-435D-87C4-FDAB71FA1773Q33875907-0A001621-5EF0-4165-B414-84CF7125DA68Q33888297-78D516F4-DB89-4F54-BFDE-54F50B9C0905Q34278051-9EE5A09D-3CB1-4814-B72D-25C6E02C81A4Q34398233-9A8AA9BC-61A3-45C3-86E2-61355AC0AAD3Q36214988-6936CDDC-345C-49A7-AFEA-F915D08B51D6Q36743937-BE68E802-6887-46CB-8D80-5BFECCBC9A19Q37116060-AE331005-9511-4F1F-A70C-8536DF40DF12Q37136953-706CC751-1F45-4BF8-9D31-9CFC422F0AD2Q37346173-B5CF7B9A-CDAD-45D8-AD7F-D845E1E977BAQ37372670-CC1E1CD8-20B8-4EA6-A675-5A320504D31AQ37400621-6991D81C-4048-4A46-AB56-A3B5BC60149BQ37411551-9985E043-AAED-4129-B664-26C3B0C40108Q37707380-85D91FFB-B701-4FF9-8C07-704EF3DBF6AEQ38402401-99C6C5AC-E226-4519-B251-89DAF9C2D5FFQ38967398-D68836B9-71F7-4716-80A7-FDBE875C08E6Q38985033-4C2E591E-49A2-44F0-81DE-103D9859E3B2Q39155563-E3430CE4-1374-47B4-BEC1-7A7E4CB0F087Q39393122-1AFD6A98-924A-4A28-971F-44B4C56C2065Q39612287-3BA46415-DFC3-4E4A-A57F-9D34645AF81CQ39651067-9BE8C9F7-EE98-4469-AB09-87D94F8FE244Q43827565-6DBAAA82-7E9C-48C4-BE5D-4FBA3722BBECQ44407211-49C0A840-EE73-4F13-AB24-9E2FBE8E3795Q47170320-F346183F-253A-42F8-8AB2-C89B7EE04477Q47969294-B95D67B4-EC44-4A46-828D-F98241382EB3Q53097080-495945AD-5B9A-4743-A988-370C493E7FC9
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The Anti-Mullerian hormone and ovarian cancer.
@ast
The Anti-Mullerian hormone and ovarian cancer.
@en
type
label
The Anti-Mullerian hormone and ovarian cancer.
@ast
The Anti-Mullerian hormone and ovarian cancer.
@en
prefLabel
The Anti-Mullerian hormone and ovarian cancer.
@ast
The Anti-Mullerian hormone and ovarian cancer.
@en
P2860
P356
P1476
The Anti-Mullerian hormone and ovarian cancer.
@en
P2093
Annibale Volpe
Antonio La Marca
P2860
P304
P356
10.1093/HUMUPD/DML060
P577
2007-01-09T00:00:00Z